°Ç±¹´ëÇб³º´¿ø ¿µ»óÀÇÇаú 2019 APECS (Advances in Peripheral EndovasCular Strategies) : 2019-11-24±³À°ÀÏÀÚ : 2019-11-24
±³À°Àå¼Ò : °Ç±¹´ëÇб³º´¿ø ´ë°´ç(B3)
±³À°ÁÖÁ¦ :
2019 APECS (Advances in Peripheral EndovasCular Strategies) ÁÖÃÖ±â°ü : °Ç±¹´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿µ»óÀÇÇаú
´ã´çÀÚ : ÇÔ»óÇù
¿¬¶ôó : 02-3144-2227
À̸ÞÀÏ :
apecsmeeting@gmail.com ±³À°Á¾·ù : ¿µ»óÀÇÇаú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í »çÀüµî·Ï½Ã µî·Ïºñ ¹«·á ÇöÀåµî·Ï½Ã Àü¹®ÀÇ:3¸¸¿ø, ±âŸ:1¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-24 09:00~09:10 How to assess treatment result for CVI? Á¤ÇõÀç(ºÎ»êÀÇ´ë ¾ç»ê)
±³À°½Ã°£ 11-24 09:10~09:20 Things you need to know when you begin US examination ÀåÀϼö(¼ö¿µ»óÀÇÇÐ)
±³À°½Ã°£ 11-24 09:20~09:50 Live Case 1. Thermal ablation ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 11-24 09:50~10:00 What unique refluxes and unusual anatomical variations should we know during ultrasound? ±è¹ÌÇü(°¡Å縯ÀÇ´ë ÀºÆò)
±³À°½Ã°£ 11-24 10:00~10:10 Important meanings of US control panel: How to use them? À¯ÈçÁ¦(ij³íÄÚ¸®¾Æ)
±³À°½Ã°£ 11-24 10:10~10:20 Venous pain: How to differentiate and how to manage it? ³ëȯ±Ô(ÇÏÆ®À£ÀÇ¿ø)
±³À°½Ã°£ 11-24 10:20~10:30 APECS meets IVDT symposium : What venous issues were hot in the past IVDT? Á¶ÁøÇö(°æÈñÀÇ´ë)
±³À°½Ã°£ 11-24 10:30~10:50 Coffee break ()
±³À°½Ã°£ 11-24 10:50~11:20 Live Case 2. Thermal ablation ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 11-24 11:20~11:30 How to make standardization for EVLT regarding wavelength, LEED, and fiber tips? À̰溹(¼¿ïÀÇ·á¿ø)
±³À°½Ã°£ 11-24 11:30~11:40 Can 1940nm laser overcome shortcomings of previous endovenous lasers? ¹ÚÀμö(ÂüÇÏÁö¿Ü°ú)
±³À°½Ã°£ 11-24 11:40~11:50 New radiofrequency catheter came up. What is different? ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 11-24 11:50~12:20 Live Case 3. Venaseal ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 11-24 12:20~12:30 Do we still need to believe in the superiority of radiofrequency over EVLT since ¡°RECOVERY¡± study? Â÷´ë¿ø(»ï¼ºÈäºÎ¿Ü°úÀÇ¿ø)
½Ä»ç 11-24 12:30~13:10 Lunch ()
±³À°½Ã°£ 11-24 13:10~13:50 Special Lecture: 2020³â °Ç°º¸Çè Á¤Ã¥¹æÇâ (ÇÏÁöÁ¤¸Æ·ù¿Í Ç÷°üÃÊÀ½ÆÄ ÁúÀÇ ÀÀ´ä Æ÷ÇÔ) ÀÌÁß±Ô(º¸°Çº¹ÁöºÎ º¸Çè±Þ¿©°ú)
±³À°½Ã°£ 11-24 13:50~14:00 Hydrophilic guide wire is necessary to increase technical success of endovenous treatment? ȲÁøÈ£(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 11-24 14:00~14:10 What hurdles do we tend to face during VenaSeal treatment? How to overcome them? ±è°Ç¿ì(¹ÎÆ®º´¿ø)
±³À°½Ã°£ 11-24 14:10~14:20 How to reduce and manage phlebitis or any other complications after VenaSeal À̱æ¼ö(Á¦ÁÖ¼öÈäºÎ¿Ü°ú)
±³À°½Ã°£ 11-24 14:20~14:30 Do we need to make even distribution of sclerosant during MOCA? How to increase technical or clinical success rate? À̽Âö(ÆíÇÑÇÏÁöÈäºÎ¿Ü°ú)
±³À°½Ã°£ 11-24 14:30~15:00 Live Case 4. MOCA ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 11-24 15:00~15:10 What are the limitations or contraindications for MOCA? °øÁØÇõ(¸ÞµðÇ÷º½º¼¼Á¾º´¿ø)
±³À°½Ã°£ 11-24 15:10~15:20 How to select endovenous devices according to lesion characteristics ±èÇâ°æ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-24 15:20~15:30 Coffee break ()
±³À°½Ã°£ 11-24 15:30~15:40 How to reduce infection related to PICC ¿ÀÇàÁø(ÀÎÁ¦ÀÇ´ë ¼¿ï)
±³À°½Ã°£ 11-24 15:40~15:50 What are differences among many PICCs in Korea? What do we need to consider before picking up? ¼Û¸í±Ô(°í·ÁÀÇ´ë ±¸·Î)
±³À°½Ã°£ 11-24 15:50~16:00 Is subclavian vein really thrombogenic? Do we need to avoid it? ±è¿ëÀç(¼øõÇâÀÇ´ë ¼¿ï)
±³À°½Ã°£ 11-24 16:00~16:10 What is the preliminary result of multicenter retrospective study regarding risk factors for PICC associated complications? ±èÀÀÅÂ(ÇѾç´ëÇб³ ±¸¸®)
±³À°½Ã°£ 11-24 16:10~16:20 No route in limb for hemodialysis: Hero and Surfacer can give us the solution. ¾ç½ÂºÎ(¼øõÇâÀÇ´ë ±¸¹Ì)
±³À°½Ã°£ 11-24 16:20~16:30 No route in limb for hemodialysis: Transrenal insertion of Perm-cath may serve as an alternative route ½ÅÁöÈÆ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-24 16:30~16:40 Repair vs. exchange of malfunctioning perm-cath: Which one is better? Á¶¼º±â(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-24 16:40~16:45 New PICC catheter development: KUH research result ¹ÎÁö¿µ(°Ç±¹ÀÇ´ë)
Åä·Ð 11-24 16:45~16:55 Discussion ()
±âŸ 11-24 16:55~17:00 Closing Remark ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë)